Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.09
-0.11 (-1.77%)
Aug 14, 2025, 11:49 AM - Market open
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$52,932
Profits / Employee
-$2,542,366
Market Cap
101.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 2 | 33.33% |
| Dec 31, 2022 | 6 | 0 | - |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COYA News
- 2 days ago - Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update - PRNewsWire
- 21 days ago - Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson's Disease - Business Wire
- 23 days ago - Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025 - Business Wire
- 2 months ago - Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025 - Business Wire
- 2 months ago - Coya Therapeutics Announces Issuance of New U.S. Patent Protecting Methods of Producing Recombinant Human (rh) Interleukin-2 (aldesleukin) Liquid Formulations - Business Wire
- 3 months ago - Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference - Business Wire
- 3 months ago - Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update - Business Wire
- 3 months ago - Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025 - Business Wire